Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence and a crude mortality exceeding 50%. Numerous treatment options are available yet comparative studies have not identified optimal therapy. METHODS: We conducted an individual patient-level quantitative review of randomized trials for treatment of IC and to assess the impact of host-, organism-, and treatment-related factors on mortality and clinical cure. Studies were identified by searching computerized databases and queries of experts in the field for randomized trials comparing the effect of ≥2 antifungals for treatment of IC. Univariate and multivariable analyses were performed to determine factors associated with patient outcomes. RESULTS: Data from 1915 patients were obtained from 7 trials. Overall mortality among patients in the entire data set was 31.4%, and the rate of treatment success was 67.4%. Logistic regression analysis for the aggregate data set identified increasing age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02; P = .02), the Acute Physiology and Chronic Health Evaluation II score (OR, 1.11; 95% CI, 1.08-1.14; P = .0001), use of immunosuppressive therapy (OR, 1.69; 95% CI, 1.18-2.44; P = .001), and infection with Candida tropicalis (OR, 1.64; 95% CI, 1.11-2.39; P = .01) as predictors of mortality. Conversely, removal of a central venous catheter (CVC) (OR, 0.50; 95% CI, .35-.72; P = .0001) and treatment with an echinocandin antifungal (OR, 0.65; 95% CI, .45-.94; P = .02) were associated with decreased mortality. Similar findings were observed for the clinical success end point. CONCLUSIONS: Two treatment-related factors were associated with improved survival and greater clinical success: use of an echinocandin and removal of the CVC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies do, however, suggest that mortality may increase after intervals exceeding 3-5 hours from hospital arrival and/or sepsis recognition (98,111,119,120).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Two RCTs have been published (119, 120); one failed to achieve a difference in time-to-antimicrobials between arms (120) and the other found no significant difference in mortality despite a 90-minute difference in median time interval to antimicrobial administration (119).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Source control of infectious foci was associated with improved survival in recent observational and cluster randomized studies (120,263,264).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [120]
In the citing paper
“Treatment with FLC often fails despite isolates being drug susceptible when tested in vitro, and rates of persistent candidemia are often higher in patients treated with FLC rather than with echinocandins 58 .”
From Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia (2018) · cites this paper as [58]
In the citing paper
“The most recent Infectious Disease Society of America (IDSA)125 and European guidelines126,127 recommend echinocandins as first-line initial treatment for most invasive candidiasis in both neutropenic and non-neutropenic patients prior to identification to the species level due to their broad spectrum of activity, favorable side effect profile, mortality benefit, and the increasing incidence of az”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [130]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 3×
“mon cause of nosocomial bloodstream infection [1–4].”
BackgroundMermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Biofilms and Device-Associated Infections
Donlan, R. M. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010226 · Cited by 1,504
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cited by
Items 201–300 of 804
de Almeida, J. N., Francisco, E. C., Holguín, A. M., Cuellar, L. E., Aquino, V. R., Mendes, A. V. A., Queiroz‐Telles, F., Santos, D. W. D. C. L., Guimarães, T., Chaves, G. M., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab085 · Cited by 48
Chiotos, K., Vendetti, N., Zaoutis, T. E., Baddley, J., Ostrosky-Zeichner, L., Pappas, P., & Fisher, B. T. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw305 · Cited by 48
Self-citationDaneshnia, F., de Almeida, J. N., Arastehfar, A. A., Lombardi, L., Shor, E., Moreno, L., Mendes, A. V. A., Barberino, M. G., Thomaz, D. Y., Butler, G., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2117093 · Cited by 56
Role of the extracellular matrix in Candida biofilm antifungal resistance
Massey, J., Żarnowski, R., & Andes, D. R. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad059 · Cited by 52
Self-citationCandidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment
Cabrera-Guerrero, J. P., García-Salazar, E., Hernández‐Silva, G., Herrera, A. C., Martínez-Herrera, E. O., Pinto‐Almazán, R., León, M. G. F.-D., & Castro-Fuentes, C. A. (2025) · Pathogens · doi:10.3390/pathogens14080806 · Cited by 52
Luzzati, R., Merelli, M., Ansaldi, F., Rosin, C., Azzini, A. M., Cavinato, S., Brugnaro, P., Vedovelli, C., Cattelan, A. M., Busetti, M., et al. (2016) · Infection · doi:10.1007/s15010-016-0924-9 · Cited by 48
The Host’s Reply to Candida Biofilm
Nett, J. E. (2016) · Pathogens · doi:10.3390/pathogens5010033 · Cited by 46
Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship
Mellinghoff, S. C., Hartmann, P., Cornely, F. B., Knauth, L., Koehler, F. C., Köhler, P., Krause, C., Kronenberg, C., Kranz, S.-L., Menon, V. P., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3285-8 · Cited by 49
Ko, J., Jung, D. S., Lee, J. Y., Kim, H. A., Ryu, S. Y., Jung, S., Joo, E., Cheon, S., Ys, K., Kim, S., et al. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.05.017 · Cited by 46
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W. Y., & Li, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01401 · Cited by 54
Martial, L. C., Brüggemann, R. J. M., Schouten, J. A., van Leeuwen, H. J., van Zanten, A. R. H., de Lange, D. W., Muilwijk, E. W., Verweij, P. E., Burger, D. M., Aarnoutse, R. E., et al. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0347-2 · Cited by 45
for the COMIC Study Group, Vena, A., Bouza, E., Corisco, R., Machado, M., Valerio, M., Sánchez, C., & Muñoz, P. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00281-x · Cited by 45
Self-citationSusceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch131 · Cited by 46
Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 51
Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options
Amann, V., Kissmann, A., Firacative, C., & Rosenau, F. (2025) · Pharmaceuticals · doi:10.3390/ph18040460 · Cited by 48
Impact of special patient populations on the pharmacokinetics of echinocandins
Muilwijk, E. W., Lempers, V. J. C., Burger, D. M., Warris, A., Pickkers, P., Aarnoutse, R. E., & Brüggemann, R. J. M. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1028366 · Cited by 49
Acute disseminated candidiasis with skin lesions: a systematic review
Guaraná, M., & Nucci, M. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.016 · Cited by 44
Jørgensen, K. M., Astvad, K. M. T., Hare, R. K., & Arendrup, M. C. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-19 · Cited by 42
Candida albicans and Antifungal Peptides
de Freitas, C. G., & Felipe, M. S. S. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00889-9 · Cited by 45
The Candida Genome Database: annotation and visualization updates
Lew-Smith, J., Binkley, J., & Sherlock, G. (2025) · Genetics · doi:10.1093/genetics/iyaf001 · Cited by 44
Astvad, K. M. T., Sanglard, D., Delarze, E., Hare, R. K., & Arendrup, M. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-18 · Cited by 43
Huang, H., Lu, P., Wang, Y., Chen, T., Chang, K., & Lin, S. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.029 · Cited by 47
Agnelli, C., Valerio, M., Bouza, E., Guinea, J., Sukiennik, T., Guimarães, T., Queiroz‐Telles, F., Muñóz, P., & Colombo, A. L. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100117 · Cited by 48
Lagunes, L., Rey-Perez, A., Martín-Gómez, M. T., Vena, A., de Egea, V., Muñóz, P., Bouza, E., Díaz‐Martín, A., Palacios-García, I., Garnacho‐Montero, J., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2775-9 · Cited by 46
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
Lepak, A. J., Castanheira, M., Diekema, D. J., Pfaller, M. A., & Andes, D. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01102-12 · Cited by 45
Self-citationLópez-Cortés, L. E., Almirante, B., Cuenca‐Estrella, M., Garnacho‐Montero, J., Padilla, B., Puig‐Asensio, M., Ruíz-Camps, I., Rodríguez‐Baño, J., Padilla, B., Muñóz, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.008 · Cited by 44
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Muñóz, P., Vena, A., Machado, M., Martínez‐Jiménez, M. D. C., Gioia, F., Gómez, E., Origüen, J., Orellana, M. Á., López‐Medrano, F., Pérez-Granda, M. J., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky048 · Cited by 43
Secular trends of candidemia at a Brazilian tertiary care teaching hospital
Braga, P. R., Cruz, I. L., Ortiz, I., Barreiros, G., Nouér, S. A., & Nucci, M. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.07.008 · Cited by 46
Wang, Z., Zhu, Y.-Y., Yi, X., Zhou, Z.-S., He, Y., Zhou, Y. M., Qi, Z., Jin, D., Zhao, L., & Luo, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113119 · Cited by 42
Emerging drugs and vaccines for Candidemia
Moriyama, B., Gordon, L. A., McCarthy, M. W., Henning, S. A., Walsh, T. J., & Penzak, S. R. (2014) · Mycoses · doi:10.1111/myc.12265 · Cited by 45
Fungal infections in the ICU: advances in treatment and diagnosis
PASCALE, G. D., & Tumbarello, M. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000230 · Cited by 47
Brüggemann, R. J. M., Middel-Baars, V., de Lange, D. W., Colbers, A. P. H., Girbes, A. R. J., Pickkers, P., & Swart, E. L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01894-16 · Cited by 42
Giuliano, S., Guastalegname, M., Russo, A., Falcone, M., Ravasio, V., Rizzi, M., Bassetti, M., Viale, P., Pasticci, M. B., Durante‐Mangoni, E., et al. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1372749 · Cited by 46
Kumar, A., Zarychanski, R., Pisipati, A., Kumar, A., Kethireddy, S., & Bow, E. J. (2018) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2017.1421592 · Cited by 47
Alkharashi, N., AlJohani, S. M., Layqah, L. A., Masuadi, E., Baharoon, W., Al-Jahdali, H. H., & Baharoon, S. A. (2019) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2019/2015692 · Cited by 50
Asai, N., Ohashi, W., Sakanashi, D., Suematsu, H., Kato, H., Hagihara, M., Watanabe, H., Shiota, A., Koizumi, Y., Yamagishi, Y., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05719-8 · Cited by 43
Martial, L. C., ter Heine, R., Schouten, J. A., Hunfeld, N., van Leeuwen, H. J., Verweij, P. E., de Lange, D. W., Pickkers, P., & Brüggemann, R. J. M. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0509-5 · Cited by 43
Clancy, C. J., & Nguyen, M. H. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.919853 · Cited by 42
Adhesion and biofilm formation by the opportunistic pathogen Candida tropicalis: what do we know?
de Souza, C. M., dos Santos, M. M., Furlaneto-Maia, L., & Furlaneto, M. C. (2023) · Canadian Journal of Microbiology · doi:10.1139/cjm-2022-0195 · Cited by 44
The epidemiology of non‐Candida yeast isolated from blood: The Asia Surveillance Study
Lin, S., Lu, P., Tan, B. H., Chakrabarti, A., Wu, U., Yang, J.-H., Patel, A. K., Li, R. Y., Watcharananan, S. P., Liu, Z., et al. (2018) · Mycoses · doi:10.1111/myc.12852 · Cited by 45
Micafungin: A Review of its Use in the Prophylaxis and Treatment of Invasive Candida Infections
Scott, L. J. (2012) · Drugs · doi:10.2165/11209970-000000000-00000 · Cited by 44
Bienvenu, A., Pradat, P., Guérin, C., Aubrun, F., Fellahi, J.-L., Friggeri, A., Guichon, C., Hernu, R., Ménotti, J., Monard, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.037 · Cited by 40
Кirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
T2 Magnetic Resonance for Fungal Diagnosis
Zervou, F. N., Zacharioudakis, I. M., Kurpewski, J., & Mylonakis, E. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_18 · Cited by 39
Liu, F., Zhong, L., Zhou, F., Zheng, C., Zhang, K., Cai, J., Zhou, H., Tang, K., Dong, Z., Cui, W., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s323583 · Cited by 41
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Ruhnke, M., & Schwartz, S. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716656381 · Cited by 37
Bloodstream infections in internal medicine
Bono, V. D., & Giacobbe, D. R. (2016) · Virulence · doi:10.1080/21505594.2016.1140296 · Cited by 42
Year in review 2011: Critical Care - infection
Afshari, A., Pagani, L., & Harbarth, S. (2012) · Critical Care · doi:10.1186/cc11421 · Cited by 37
Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient
Sari, A. P., Darnindro, N., Djojo, A. Y., & Mokoagow, M. I. (2021) · Medicine · doi:10.1097/md.0000000000025173 · Cited by 37
Trécourt, A., Rabodonirina, M., Mauduit, C., Traverse‐Glehen, A., Devouassoux‐Shisheboran, M., Meyronet, D., Dijoud, F., Ginévra, C., Chapey, E., Josse, E., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.01520-22 · Cited by 36
Direct Detection of Pathogens in Bloodstream During Sepsis: Are We There Yet?
Samuel, L. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.028274 · Cited by 39
Alothman, A. F., Al-Musawi, T., Al-Abdely, H. M., Salman, J. A., Almaslamani, M., Yared, N., Butt, A. A., Raghubir, N., Morsi, W. E., & Althaqafi, A. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.08.002 · Cited by 41
Heimann, S. M., Cornely, O. A., Wisplinghoff, H., Kochanek, M., Stippel, D. L., Padosch, S. A., Langebartels, G., Reuter, H., Reiner, M., Vierzig, A., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2230-8 · Cited by 37
Usefulness of guideline recommendations for prognosis in patients with candidemia
Cuervo, G., García‐Vidal, C., Puig‐Asensio, M., Merino, P., Vena, A., Martín‐Peña, A., Montejo, J. M., Gaitán, A. C. R., Lázaro-Perona, F., Fortün, J., et al. (2018) · Medical Mycology · doi:10.1093/mmy/myy118 · Cited by 39
Decreasing rates of invasive candidiasis in pediatric hospitals across the United States.
Fisher, B. T., Ross, R. K., Localio, A. R., Prasad, P. A., & Zaoutis, T. E. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit679 · Cited by 35
Liu, N., Acosta‐Zaldívar, M., Qi, W., Diray‐Arce, J., Walker, L. A., Kottom, T. J., Kelly, R. S., Yuan, M., Asara, J. M., Lasky-Su, J. A., et al. (2020) · mBio · doi:10.1128/mbio.03225-19 · Cited by 36
Advances in the diagnosis of fungal pneumonias
Kelly, B. T., Pennington, K. M., & LIMPER, A. H. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1753506 · Cited by 36
Jung, P., Mischo, C. E., Gunaratnam, G., Spengler, C., Becker, S. L., Hube, B., Jacobs, K., & Bischoff, M. (2020) · Virulence · doi:10.1080/21505594.2020.1836902 · Cited by 35
Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia
Omrani, A. S., Makkawy, E. A., Baig, K., Baredhwan, A. A., Almuthree, S. A., Elkhizzi, N. A., & Albarrak, A. M. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6005 · Cited by 37
Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity
Denis, J., Ledoux, M., Nivoix, Y., & Herbrecht, R. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.02.005 · Cited by 34
Kwon, Y. J., Won, E. J., Jeong, S. H., Shin, K. S., Shin, J. H., Kim, Y. R., Kim, Y. R., Kim, H. S., Kim, Y. A., Kim, T. S., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080597 · Cited by 37
Invasive candidiasis: update on current pharmacotherapy options and future perspectives
Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 40
Bruyère, R., Quenot, J., Prin, S., Dalle, F., Vigneron, C., Aho, S., León, C., & Charles, P. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-385 · Cited by 37
How to select an antifungal agent in critically ill patients
Dimοpoulos, G., Antonopoulou, A., Armaganidis, A., & Vincent, J. (2013) · Journal of Critical Care · doi:10.1016/j.jcrc.2013.04.006 · Cited by 35
Time of catheter removal in candidemia and mortality
Nucci, M., Braga, P. R., Nouér, S. A., & Anaissie, E. J. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2018.10.278 · Cited by 33
Doğan, Ö., Yesilkaya, A., Menekşe, Ş., Güler, Ö., Karakoç, Ç., Çınar, G., Kapmaz, M., Aydın, M., Keske, Ş., Şahin, S., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105992 · Cited by 36
A new humanized antibody is effective against pathogenic fungi in vitro
Mambro, T. D., Vanzolini, T., Bruscolini, P., Perez-Gaviro, S., Marra, E., Roscilli, G., Bianchi, M., Fraternale, A., Schiavano, G. F., Canonico, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-98659-5 · Cited by 36
Kang, H. M., Lee, H. J., Cho, E. Y., Yu, K., Lee, H., Lee, J., Kang, H. J., Park, K. D., Shin, H. Y., & Choi, E. H. (2015) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2015.1088905 · Cited by 35
Gong, Y., Li, C., Wang, C., Li, J., Ding, M., Chen, D., & Lao, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s242187 · Cited by 32
Berg, T., Aehling, N., Bruns, T., Welker, M., Weismüller, T. J., Trebicka, J., Tacke, F., Strnad, P., Sterneck, M. R., Settmacher, U., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2255-7246 · Cited by 32
Mete, B., Zerdali, E. Y., Aygün, G., Saltoğlu, N., Balkan, İ. İ., Karaali, R., Kaya, S. Y., Karaismailoglu, B., Kaya, A., Ürkmez, S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03994-6 · Cited by 36
Burden of Serious Fungal Infections in Jordan
Wadi, J., & Denning, D. W. (2018) · Journal of Fungi · doi:10.3390/jof4010015 · Cited by 33
Giacobbe, D. R., Esteves, P., Bruzzi, P., Mikulska, M., Furfaro, E., Mesini, A., Tatarelli, P., Grignolo, S., Viscoli, C., Colombo, A. L., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.002 · Cited by 35
The End of an Era in Defining the Optimal Treatment of Invasive Candidiasis
Clancy, C. J., & Nguyen, M. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis023 · Cited by 31
Schroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 31
Self-citationMenichetti, F., Bertolino, G., Sozio, E., Carmignani, C., Turco, E. R. D., Tagliaferri, E., Sbrana, F., Ripoli, A., Barnini, S., Desideri, I., et al. (2018) · Journal of Chemotherapy · doi:10.1080/1120009x.2018.1507086 · Cited by 30
de Oliveira, C. S., Colombo, A. L., Francisco, E. C., de Lima, B., Gandra, R. F., de Carvalho, M. C. P., Carrilho, C. M. D. D. M., Petinelli, R. P., Pelisson, M., Helbel, C., et al. (2020) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2020.11.006 · Cited by 33
Li, R., Zhu, L., Liu, D., Wang, W., Zhang, C., Jiao, S., Wei, J., Ren, L., Zhang, Y., Gou, X., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119253 · Cited by 32
Our 2014 approach to candidaemia
Koehler, P. A., Tacke, D., & Cornely, O. A. (2014) · Mycoses · doi:10.1111/myc.12207 · Cited by 32
Future therapies targeted towards eliminatingCandidabiofilms and associated infections
Bandara, N., Matsubara, V. H., & Samaranayake, L. P. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1268530 · Cited by 39
Lin, S., Chen, R., Zhu, S., Wang, H., Wang, L., Zou, J., Yan, J., Zhang, X., Farmakiotis, D., Tan, X., et al. (2018) · Mycopathologia · doi:10.1007/s11046-018-0258-5 · Cited by 33
Essentials in Candida bloodstream infection
Mellinghoff, S. C., Cornely, O. A., & Jung, N. (2018) · Infection · doi:10.1007/s15010-018-1218-1 · Cited by 32
Epidemiology and prognosis of candidaemia in elderly patients
Ramos, A., López, N. V., Sánchez‐Romero, I., Padilla, B., Amador, P. M., Garnacho‐Montero, J., Ruíz-Camps, I., Montejo, M., Salavert, M., Mensa, J., et al. (2017) · Mycoses · doi:10.1111/myc.12677 · Cited by 31
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C., Cuervo, G., Salavert, M., Merino, P., Gioia, F., Fernández‐Ruiz, M., López-Cortés, L. E., Escolà‐Vergé, L., Montejo, M., Muñóz, P., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz491 · Cited by 29
Apsemidou, A., Füller, M. A., Idelevich, E. A., Kurzai, O., Tragiannidis, A., & Groll, A. H. (2020) · Journal of Fungi · doi:10.3390/jof6040380 · Cited by 29
Methylene blue and its importance in medicine
Kayabaşı, Y. (2020) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2020.25035 · Cited by 32
Demir, K. K., Butler‐Laporte, G., Corpo, O. D., Ekmekjian, T., Sheppard, D. C., Lee, T. C., & Cheng, M. P. (2021) · Mycoses · doi:10.1111/myc.13290 · Cited by 33
Immunopathogenesis of Emerging Candida auris and Candida haemulonii Strains
Pharkjaksu, S., Boonmee, N., Mitrpant, C., & Ngamskulrungroj, P. (2021) · Journal of Fungi · doi:10.3390/jof7090725 · Cited by 31
Micafungin: an evidence-based review of its place in therapy
Reboli, A. C., & de la Torre (2014) · Core evidence · doi:10.2147/ce.s36304 · Cited by 31
Self-citationComplications of hematopoietic stem transplantation: Fungal infections
Omrani, A. S., & Almaghrabi, R. S. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.013 · Cited by 30
Murakami, M., Komatsu, H., Sugiyama, M., Ichikawa, Y., Ide, K., Tsuchiya, R., Kunieda, K., Magishi, A., Akiyama, G., 三浦, 文., et al. (2018) · Journal of General and Family Medicine · doi:10.1002/jgf2.159 · Cited by 31
The progress and future of the treatment of Candida albicans infections based on nanotechnology
Gao, Y., Cao, Q., Xiao, Y., Wu, Y., Ding, L., Huang, H., Li, Y., Yang, J., & Meng, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02841-6 · Cited by 33
Neoh, C. F., Slavin, M. A., Chen, S. C. ‐., Stewart, K., & Kong, D. C. M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.010 · Cited by 32
Cardiac effects of echinocandin preparations - three case reports
Lichtenstern, C., Wolff, M., Arens, C., Klie, F., Majeed, R. W., Henrich, M., Uhle, F., Weiterer, S., Röhrig, R., & Weigand, M. A. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12078 · Cited by 29
Fernández‐Ruiz, M., Guinea, J., Lora, D., Zaragoza, Ó., Puig‐Asensio, M., Almirante, B., Cuenca‐Estrella, M., Aguado, J. M., Padilla, B., Muñóz, P., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.014 · Cited by 28
Keane, S., Geoghegan, P., Póvoa, P. M. S. R., Nseir, S., Rodríguez, A. H., & Martín‐Loeches, I. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1528872 · Cited by 31
Invasive Candidiasis: Epidemiology and Risk Factors
Cortés, J. A., & Corrales, I. F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81813 · Cited by 34
Kim, J. H., Suh, J. W., & Kim, M. J. (2021) · Journal of Fungi · doi:10.3390/jof7040275 · Cited by 28
Metadata
- Authors
- Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group
- Affiliations
- University of Wisconsin–Madison (US)
- University of Alabama at Birmingham (US)
- The University of Queensland (AU)
- Rutgers, The State University of New Jersey (US)
- AstraZeneca (United States) (US)
- Wayne State University (US)
- Radboud University Nijmegen (NL)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-12
- Volume
- 54
- Issue
- 8
- Pages
- 1110-1122
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2134827411
- Cited by
- 793
- References
- 72
- Citations by year
- 2026: 20 · 2025: 46 · 2024: 46 · 2023: 45 · 2022: 42 · 2021: 64 · 2020: 81 · 2019: 46 · 2018: 71 · 2017: 69 · 2016: 58 · 2015: 62 · 2014: 60 · 2013: 54 · 2012: 28
- FWCI
- 45.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive candidiasis, candidemia, antifungal therapy, echinocandins, central venous catheter removal, mortality, clinical cure, risk factors, immunosuppression, Candida tropicalis, APACHE II score
- MeSH terms
- Adult, Aged, Antifungal Agents, Catheterization, Central Venous, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Echinocandins, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.